Skip to content

Disposable Powered Articulating Linear Cutter Stapler in Gastrointestinal Tissue Cutting and Anastomosis

Clinical Trial of Efficacy and Safety of Fengh Disposable Powered Articulating Endoscopic Linear Cutter Stapler Used for Gastrointestinal Tissue Cutting and Anastomosis

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05320029
Enrollment
164
Registered
2022-04-11
Start date
2018-08-30
Completion date
2022-01-20
Last updated
2023-12-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastrointestinal Neoplasm

Brief summary

To evaluate whether the anastomosis success rate of the main effectiveness evaluation indexes is not inferior to the similar products produced by Johnson & Johnson when the Fengh Disposable Powered Articulating Endoscopic Linear Cutter Stapler Used for Gastrointestinal Tissue Cutting and Anastomosis

Detailed description

In this clinical trial, prospective, multi-center, stratified group randomization, incomplete blind setting, parallel positive control and non-inferiority test were used to evaluate the Disposable Powered Articulating Endoscopic Linear Cutter Stapler manufactured by Jiangsu Fengh Medical Co., Ltd. when used for gastrointestinal tissue cutting and anastomosis. To determine whether there is any difference in the incidence of adverse events, serious adverse events, device defects and other safety evaluation indicators compared with similar products produced by Johnson & Johnson.

Interventions

Using the Disposable Powered Articulating Endoscopic Linear Cutter Stapler according to routine treatment

Using the ECHELON Flex Powered Articulating Endoscopic Linear Cutters according to routine treatment

Sponsors

Fengh Medical Co., Ltd.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Masking description

A test method in which subjects are not told whether they are a trial device or a control device in order to control intentional or unintentional bias in the course of a clinical trial and in the interpretation of results

Intervention model description

Patients randomized to the trial group and the control group will not cross use the product

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

1. The subjects are 18 \ 75 years old, regardless of gender: 2. Subjects need to use a linear stapler for gastrointestinal tissue cutting and anastomosis: 3. The subject or his legal representative can understand the purpose of the study and show sufficient compliance with the study protocol And sign informed consent.

Exclusion criteria

1. The subject plans to perform emergency gastrointestinal surgery: 2. Subjects with moderate malnutrition (BML \< 17kg / m2) and severe anemia (HB \< 60g / L): 3. Subject BMI 228kg / m2; 4. Subject platelet (PLT) \< 60x 109 / L or international normalized ratio (INR) \> 1.5; 5. Subject forced expiratory volume per second (FEV1) / expected value ≤ 50%, or forced expiratory volume per second (FEV1) / forced vital capacity (FCV) \< 60%; 6. Subject's cardiac ejection fraction ≤ 50%; 7. Have important organ failure or other serious diseases (e.g. preoperative subject aspartate amino acid) Transferase (AST), or alanine aminotransferase (ALT), or serum creatinine (SER) exceeds normal values Upper limit 3 times and above: subjects with fasting blood glucose value \> 10.0mmol/l before operation: 8. The subjects were pregnant or lactating women; Page 16 of 53 Version No.: 1.1/version date 20190125 Clinical trial on the efficacy and safety of linear cutting stapler and components for disposable electric endoscopy for cutting and anastomosis of gastrointestinal tissue 9. Subjects participated in clinical trials of other drugs or devices within 3 months before the trial; 10. Other conditions that the researchers judged not suitable for inclusion.

Design outcomes

Primary

MeasureTime frameDescription
Number of Participants With Anastomosis SuccessDuring surgeryThe transection and anastomosis of lung tissues are performed during the operation. The device is withdrawn after successful triggering. The cutting staple line is carefully checked for integrity, air leakage and bleeding. Anastomosis is considered as successful if all anastomotic rings are intact without leakage or bleeding, otherwise it is considered as failure. If necessary, the gas injection method is used to inspect whether there is bubble overflow at anastomotic stoma. If there is no bubble overflow, it is recorded as successful anastomosis; if there is obvious bubble overflow, it is recorded as anastomosis failure.

Countries

China

Participant flow

Participants by arm

ArmCount
Disposable Powered Articulating Endoscopic Linear Cutter Stapler
Gastrointestinal tumor surgery: Only the brand of electric cutting stapler used by different groups was different, and the rest were treated according to routine treatment
80
Echelon Flex POWERED Articulating Endoscopic Linear Cutters
Gastrointestinal tumor surgery: Only the brand of electric cutting stapler used by different groups was different, and the rest were treated according to routine treatment
80
Total160

Baseline characteristics

CharacteristicDisposable Powered Articulating Endoscopic Linear Cutter StaplerEchelon Flex POWERED Articulating Endoscopic Linear CuttersTotal
Age, Continuous59.16 years
STANDARD_DEVIATION 10.85
60.40 years
STANDARD_DEVIATION 11.06
59.78 years
STANDARD_DEVIATION 10.94
BMI23.00 kg/m2
STANDARD_DEVIATION 2.45
22.83 kg/m2
STANDARD_DEVIATION 2.9
22.91 kg/m2
STANDARD_DEVIATION 2.68
Race and Ethnicity Not Collected0 Participants
Region of Enrollment
China
80 participants80 participants160 participants
Sex: Female, Male
Female
23 Participants27 Participants50 Participants
Sex: Female, Male
Male
57 Participants53 Participants110 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 801 / 80
other
Total, other adverse events
65 / 8068 / 80
serious
Total, serious adverse events
11 / 809 / 80

Outcome results

Primary

Number of Participants With Anastomosis Success

The transection and anastomosis of lung tissues are performed during the operation. The device is withdrawn after successful triggering. The cutting staple line is carefully checked for integrity, air leakage and bleeding. Anastomosis is considered as successful if all anastomotic rings are intact without leakage or bleeding, otherwise it is considered as failure. If necessary, the gas injection method is used to inspect whether there is bubble overflow at anastomotic stoma. If there is no bubble overflow, it is recorded as successful anastomosis; if there is obvious bubble overflow, it is recorded as anastomosis failure.

Time frame: During surgery

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Disposable Powered Articulating Endoscopic Linear Cutter StaplerNumber of Participants With Anastomosis Success80 Participants
Echelon Flex POWERED Articulating Endoscopic Linear CuttersNumber of Participants With Anastomosis Success80 Participants
p-value: <0.0595% CI: [-0.0458, 0.0458]Newcombe-Wilson

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026